IC Potash Corp. (TSX: ICP) (OTCQX: ICPTF) intends to become a primary producer of Sulphate of Potash ("SOP") and Sulphate of Potash Magnesia ("SOPM") by mining its 100% owned potash Ochoa property in southeast New Mexico. The property consists of over 100,000 acres of federal subsurface potassium prospecting permits and State of New Mexico potassium mining leases. http://www.icpotash.com
Keynote Systems (NASDAQ: KEYN) is the global leader in Internet and mobile cloud testing & monitoring., Keynote maintains the world's largest on-demand performance monitoring and testing infrastructure for Web and mobile sites comprised of over 7,000 measurement computers and mobile devices in over 275 locations around the world that enable companies to continuously improve the online and mobile experience. Known as 'The Mobile and Internet Performance Authority, Keynote serves over 4,000 customers. http://www.keynote.com/
Odyssey Marine Exploration, Inc. (NASDAQ: OMEX) Odyssey Marine Exploration is engaged in deep-ocean exploration using innovative methods and technology. Odyssey conducts search and archaeological operations on shipwrecks around the world. The Company also has a minority ownership stake in Neptune Minerals, whose focus is on discovering and commercializing high-value underwater mineral deposits and in Chatham Rock Phosphate, a company focused on discovering and commercializing seabed deposits of rock phosphate and other minerals. Odyssey provides contracting services to governments and global companies.http://www.shipwreck.net
OncoSec Medical Incorporated (OTCQB: ONCS) is a biopharmaceutical company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers.
ImmunoPulse and NeoPulse therapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.
OncoSec's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials.
OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com
Perceptron, Inc. (NASDAQ: PRCP) Perceptron's high tech products provide laser and software based solutions for manufacturing process control as well as non-contact measurement, scanning, and inspection applications. Perceptron's metrology solutions to help companies manage their complex manufacturing processes to improve quality, shorten product launch times and reduce overall manufacturing costs. The Company also offers Value Added Support Services. Perceptron has operations in the United States, Germany, France, Spain, Brazil, Japan, Singapore, China and India. For more information, please visit http://www.perceptron.com
Most Popular Stories
- Slow Week Ahead of December FOMC Meeting
- Hispanics Seek to Grow School Board Members
- GM Bailout Saved 1.2 Million U.S. Jobs, Report Says
- 'Knockout Game': Myth or Menace?
- Questions Remain in Jenni Rivera's Death
- U.S. Companies Eager for Iranian Business
- Bitcoin Used to Buy Tesla Car
- Banks Fret as Volcker Vote Approaches
- Paul Walker Fans Pay Respects
- Yellen Set to Become One of World's Most Powerful Women